Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart

A Mantovani1, G Lunardi2, S Bonapace3

  • 1Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126 Verona, Italy.

Diabetes & Metabolism
|April 14, 2020
PubMed

Insights

Plasma ceramide levels are elevated in patients with chronic kidney disease (CKD). These findings hold true even when accounting for heart disease and diabetes, suggesting ceramides as potential biomarkers for CKD.

Area of Science:

  • Biochemistry
  • Nephrology
  • Cardiology

Background:

  • Plasma ceramides are elevated in patients with ischemic heart disease (IHD).
  • The relationship between plasma ceramides and chronic kidney disease (CKD) is not well-established.
  • Shared risk factors exist for IHD and CKD.

Purpose of the Study:

  • To investigate whether plasma ceramide levels are increased in patients with CKD.
  • To determine the association between plasma ceramides and CKD, independent of other cardiovascular risk factors.

Main Methods:

  • Measured six specific plasma ceramide concentrations in 415 middle-aged individuals.
  • Defined CKD based on estimated glomerular filtration rate (e-GFR) and urinary albumin-to-creatinine ratio.
  • Analyzed associations after adjusting for multiple cardiovascular risk factors.

Main Results:

  • Patients with CKD exhibited significantly higher levels of all six measured plasma ceramides compared to those without CKD.
  • CKD remained significantly associated with elevated plasma ceramides after adjusting for BMI, smoking, hypertension, diabetes, IHD, LDL-cholesterol, hs-CRP, and lipid-lowering medication use.
  • Advanced CKD stages and abnormal albuminuria were independently associated with increased plasma ceramide levels.

Conclusions:

  • Elevated plasma ceramide levels are associated with CKD.
  • This association is independent of pre-existing IHD, diabetes, and other established cardiovascular risk factors.
  • Plasma ceramides may serve as potential biomarkers for CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
473
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
478
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
270
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
236
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
212
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
737